These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 2560431)

  • 61. Age-related differences in the sensitivity of serum luteinizing hormone to prototypic mu, kappa and delta opiate agonists and antagonists.
    Cicero TJ; Meyer ER; Miller BT; Bell RD
    J Pharmacol Exp Ther; 1988 Jul; 246(1):14-20. PubMed ID: 2839658
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Tolerance to hyperthermia produced by morphine in rat.
    Mucha RF; Kalant H; Kim C
    Psychopharmacology (Berl); 1987; 92(4):452-8. PubMed ID: 3114798
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Further study of kappa opioids on increased urination.
    Leander JD
    J Pharmacol Exp Ther; 1983 Oct; 227(1):35-41. PubMed ID: 6137557
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effects of a kappa-opioid agonist on adrenocorticotropic and diuretic function in man.
    Pfeiffer A; Knepel W; Braun S; Meyer HD; Lohmann H; Brantl V
    Horm Metab Res; 1986 Dec; 18(12):842-8. PubMed ID: 3028922
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Kappa 3 receptors and levorphanol-induced analgesia.
    Tive L; Ginsberg K; Pick CG; Pasternak GW
    Neuropharmacology; 1992 Sep; 31(9):851-6. PubMed ID: 1331842
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Some observations on the effects of enantiomers of two benzomorphan narcotic antagonists and atropine on analgesia, tremor and hypothermia produced by oxotremorine.
    Ben-Sreti MM; Sewell RD; Upton N
    Arch Int Pharmacodyn Ther; 1982 Apr; 256(2):219-27. PubMed ID: 7103612
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of endothelin-A receptor antagonist on mu, delta and kappa opioid receptor-mediated antinociception in mice.
    Bhalla S; Zhang Z; Patterson N; Gulati A
    Eur J Pharmacol; 2010 Jun; 635(1-3):62-71. PubMed ID: 20303944
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Effects of kappa-opiate receptor antagonist MR-2266-BS on ACTH and prolactin release].
    Xu RK; Chen L; Li H; Yang SJ; Huang XY
    Sheng Li Xue Bao; 1989 Aug; 41(4):395-401. PubMed ID: 2557673
    [TBL] [Abstract][Full Text] [Related]  

  • 69. In vivo apparent pA2 analysis for naltrexone antagonism of discriminative stimulus and analgesic effects of opiate agonists in rats.
    Walker EA; Makhay MM; House JD; Young AM
    J Pharmacol Exp Ther; 1994 Nov; 271(2):959-68. PubMed ID: 7965818
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Stereoselectivity of kappa-opiate receptor ligands in inhibiting the binding of [3H][3-MeHis2]thyrotrophin releasing hormone to brain membranes.
    Bhargava HN; Das S; Gulati A
    J Pharm Pharmacol; 1988 Jan; 40(1):70-2. PubMed ID: 2896784
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Some pharmacological properties of a newly synthesized 3-acetoxy-6 beta-acetylthio-10-oxo-N-cyclopropylmethyl-dihydronormorphine (KT-95).
    Hosoki R; Niizawa S; Koike K; Sagara T; Kanematsu K; Takayanagi I
    Arch Int Pharmacodyn Ther; 1996; 331(2):136-52. PubMed ID: 8937625
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Tolerance and morphine-induced cross-tolerance are not shown to Tyr-W-MIF-1 analgesia.
    Bell RL; Vaccarino AL; Olson RD; Olson GA; Nores WL; Cambre JG; Zadina JE; Kastin AJ
    Peptides; 1999; 20(8):971-8. PubMed ID: 10503776
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Multiple opiate receptors and pharmacological response to morphine in rats maintained on diets differing in protein concentration.
    Bhargava HN; Bansinath M; Das S; Matwyshyn GA
    Gen Pharmacol; 1987; 18(5):505-12. PubMed ID: 2820832
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Intermittent cold water stress-analgesia in rats: cross-tolerance to morphine.
    Girardot MN; Holloway FA
    Pharmacol Biochem Behav; 1984 Apr; 20(4):631-3. PubMed ID: 6728879
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Central endothelin-B receptor stimulation does not affect morphine analgesia in rats.
    Bhalla S; Matwyshyn G; Gulati A
    Pharmacology; 2004 Sep; 72(1):20-5. PubMed ID: 15292651
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Enhancement of naloxone-induced analgesia by pretreatment with morphine.
    Cappell H; Poulos CX; Lê AD
    Pharmacol Biochem Behav; 1989 Oct; 34(2):425-7. PubMed ID: 2560204
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effect of peptides on the development of tolerance to buprenorphine, a mixed opiate agonist-antagonist analgesic.
    Bhargava HN
    Eur J Pharmacol; 1982 Apr; 79(1-2):117-23. PubMed ID: 7084303
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Potentiation of morphine analgesia by BQ123, an endothelin antagonist.
    Bhalla S; Matwyshyn G; Gulati A
    Peptides; 2002 Oct; 23(10):1837-45. PubMed ID: 12383872
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Mu-opiate binding and morphine antagonism by octapeptide analogs of somatostatin.
    Walker JM; Bowen WD; Atkins ST; Hemstreet MK; Coy DH
    Peptides; 1987; 8(5):869-75. PubMed ID: 2893361
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Stress-induced potentiation of morphine-induced analgesia in morphine-tolerant rats.
    Fleetwood SW; Holtzman SG
    Neuropharmacology; 1989 Jun; 28(6):563-7. PubMed ID: 2569174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.